Search Within

Mrinal M Gounder

Formats
  1. Meeting Abstract (119)
  2. Journal Article (98)
  3. Review (4)
  4. Guidelines (2)
  5. Research Letter (2)
  6. Book Section (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (229)
  2. Sarcoma Service (229)
  3. Solid Tumor Oncology Division (229)
  4. GSK Faculty (87)
  5. Hematologic Malignancies, Division of (85)
  6. Tow Center for Developmental Oncology (TCDO) (83)

More Groups

People
  1. William Tap (78)
  2. Mary Keohan (73)
  3. Sandra D'Angelo (73)
  4. Mark Dickson (70)
  5. Ping Chi (57)
  6. Li-Xuan Qin (52)

More People

Years
  1. 2025 (6)
  2. 2024 (17)
  3. 2023 (21)
  4. 2022 (36)
  5. 2021 (16)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (86)
  2. Annals of Oncology (24)
  3. Clinical Cancer Research (20)
  4. Cancer (7)
  5. The Oncologist (6)
  6. European Journal of Cancer (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (88)
  2. Oxford University Press (30)
  3. American Association for Cancer Research (29)
  4. Springer (14)
  5. Elsevier Inc. (11)
  6. Nature Publishing Group (10)

More Publishers

Results (229)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The clinical impact of performing routine next generation sequencing (NGS) in gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Vonya, T.; Yoon, S. S.; Singer, S.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of MEK inhibitor - Associated retinopathy: Differences from central serous chorioretinopathy
    Journal Article

    Francis, J. H.; Habib, L. A.; Abramson, D. H.; Yannuzzi, L. A.; Heinemann, M.; Gounder, M. M.; Grisham, R. N.; Postow, M. A.; Shoushtari, A. N.; Chi, P.; more...
    Ophthalmology (2017)

    Fulltext@MSK | Save
  • A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel
    Journal Article

    Smyth, L. M.; Monson, K. R.; Jhaveri, K.; Drilon, A.; Li, B. T.; Abida, W.; Iyer, G.; Gerecitano, J. F.; Gounder, M.; Harding, J. J.; more...
    Investigational New Drugs (2017)

    Fulltext@MSK | Save
  • Proton quad shot RT for palliation in patients with advanced sarcoma
    Meeting Abstract

    Patel, S.; Anderson, E. S.; Kelly, C.; Dickson, M.; Gounder, M.; Keohan, M.; Iqbal, A.; Tap, W. D.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Co-amplification of KIT/KDR/PDGRA in over 100,000 advanced cancer cases
    Meeting Abstract

    Disel, U.; Madison, R.; Chung, J.; Gounder, M.; Oztan, A.; Benson, A.; Webster, J.; Klempner, S. J.; Ou, S. H. I.; Ganesan, S.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • The PARP inhibitor veliparib can be safely added to bendamustine and rituximab and has preliminary evidence of activity in B-cell lymphoma
    Journal Article

    Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Straus, D. J.; Moskowitz, A. J.; Younes, A.; Matasar, M. J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors
    Journal Article

    LoRusso, P. M.; Gounder, M.; Jalal, S. I.; AndreĢ, V.; Kambhampati, S. R. P.; Loizos, N.; Hall, J.; Holzer, T. R.; Nasir, A.; Cosaert, J.; more...
    Investigational New Drugs (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Combined KIT and CTLA-4 blockade in patients with refractory GIST and other advanced sarcomas: A phase Ib study of dasatinib plus ipilimumab
    Journal Article

    D'Angelo, S. P.; Shoushtari, A. N.; Keohan, M. L.; Dickson, M. A.; Gounder, M. M.; Chi, P.; Loo, J. K.; Gaffney, L.; Schneider, L.; Patel, Z.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Efficacy of sorafenib in patients with desmoid-type fibromatosis
    Meeting Abstract

    Munhor, R. R.; Lefkowitz, R. A.; Kuk, D.; Dickson, M. A.; D'Angelo, S. P.; Keohan, M. L.; Chi, P.; Crago, A. M.; Maki, R. G.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save